SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-023326
Filing Date
2022-08-19
Accepted
2022-08-19 13:08:05
Documents
1
Period of Report
2022-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166092887277332.html 4  
1 FORM 4 wf-form4_166092887277332.xml 4 3779
  Complete submission text file 0001628280-22-023326.txt   5302
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Meisner Derek M (Reporting) CIK: 0001752461 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 221179887